|Articles|March 1, 2003

March 2003
Volume 9
Issue 3

Slow Response to Loss of Glycemic Control in Type 2 Diabetes Mellitus

Author(s)Jonathan B. Brown, PhD, MPP, Gregory A. Nichols, PhD

Download PDF: Slow Response to Loss of Glycemic Control in Type 2 Diabetes Mellitus

Articles in this issue

over 23 years ago

Article

How Do Minor Changes in the Definition of Blood Pressure Control Affect the Reported Success of Hypertension Treatment?

over 23 years ago

Article

Physician Attitudes Toward Strategies to Promote the Adoption of Medical Evidence Into Clinical Practice

over 23 years ago

Article

Patient Reports of Coverage Denial: Association With Ratings of Health Plan Quality and Trust in Physician

over 23 years ago

Article

Restoring Trust to Managed Care, Part 2: A Focus on Physicians

over 23 years ago

Article

Review of the Newer Antiepileptic Drugs

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Woman getting her eyes checked | Image credit: N F/peopleimages.com - stock.adobe.com

Understanding Barriers to Diabetic Eye Care for Alabama’s Underserved Patients

ByStella Ko, PharmD, MS,David Tabano, PhD,Mona Kilany, PhD,Kimberly Jinnett, PhD, MSPH,Victor Kirksey, PhD,Reg Ledesma, MS,Sarah Mossburg, PhD,Charlene Nguyen, MPP, BSc,Bryan A. Wilson, PhD, MBA

September 15th 2026

Doctor talking with patient | Image credit: Prostock-studio - stock.adobe.com

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

ByAayush Sisodia, MSHI, BDS

September 15th 2026

Man with chest pain | Image credit: Liubomir - stock.adobe.com

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

ByHector P. Rodriguez, PhD, MPH, Hattie R. Hanley, MPP,Stephen M. Shortell, PhD, MBA, MPH

September 15th 2026

Pregnant woman | Image credit: pressmaster - stock.adobe.com

Early Signs of Success for Missouri’s New Notification of Pregnancy

ByAbigail R. Barker, PhD,Nadim Kanafani, MD,Kelley M. Peters, MS, RN, BSN,Rashmi Srivastava, MD, BS

September 15th 2026

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Slow Response to Loss of Glycemic Control in Type 2 Diabetes Mellitus

Articles in this issue

Related Content

Understanding Barriers to Diabetic Eye Care for Alabama’s Underserved Patients

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

Early Signs of Success for Missouri’s New Notification of Pregnancy

Predicting GLP-1 Discontinuation From Pharmacy Claims

Trending on AJMC

FDA Clears First Alzheimer Blood Test for Adults as Young as 40

RSV Vaccine Shows 100% Effectiveness in COPD: Jorgen Vestbo, MD

5 Things to Know About the 2026 ESC Heart Failure Guidelines

FDA Shortens Tarlatamab Monitoring, Widens Access to SCLC Care

Enlicitide, Oral PCSK9 Inhibitor, Cuts LDL 60% in CORALreef Trials